| Amy L Dizol, PHARMD | |
|
3026 Owen Dr, Suite 116, Antioch, TN 37013-2417 | |
| (615) 641-3845 | |
| (615) 641-3846 |
| Full Name | Amy L Dizol |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3026 Owen Dr, Antioch, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750419214 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 21868 (Tennessee) | Primary |
| 183500000X | Pharmacist | 14948 (Alabama) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Amy L Dizol, PHARMD 3730 Henricks Hill Dr, Smyrna, TN 37167-6181 Ph: (615) 220-6345 | Amy L Dizol, PHARMD 3026 Owen Dr, Suite 116, Antioch, TN 37013-2417 Ph: (615) 641-3845 |
News Archive
But this is no church service, and nurses are not here to worship. The California Nurses Association is rousing its troops for battle. California's powerful nurses' union will begin bargaining next week with Kaiser Permanente on a new four-year contract for nurses at its Northern California hospitals. (Kaiser Health News is not affiliated with Kaiser Permanente.) Kaiser operates the largest hospital system in the state, by number of hospitals and number of hospital beds, and is the eighth largest health system in the country (Dembosky, 7/22).
For some people, alcohol is a social lubricant. For others, it's an unpleasant downer. New research shows that a person's response to alcohol can predict their future drinking behavior, including their frequency of binge drinking and the risk of developing an alcohol-use disorder.
NICE has today issued guidance for the use of the targeted biological therapies, Enbrel (etanercept) and Raptiva (efalizumab), to treat adult patients with severe plaque psoriasis.
Salix Pharmaceuticals, Ltd. today announced the successful outcome of two Phase 3, randomized, double-blind, placebo-controlled, multicenter trials, TARGET 1 and TARGET 2, designed to evaluate the efficacy and safety of rifaximin 550 mg TID in the treatment of patients with non-constipation irritable bowel syndrome (non-C IBS).
› Verified 6 days ago
Deleca Latrice Reynolds-barnes, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2401 Edge O Lake Dr, Antioch, TN 37013 Phone: 615-645-1892 | |
Ashley Mcmahan Rich, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1301 Bell Rd, Antioch, TN 37013 Phone: 615-837-6990 | |
Aida Attia Faltas, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 608 Copper Rideg Trail, Antioch, TN 37013 Phone: 615-710-0464 | |
Jessica L Roberts, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1809 Antioch Pike, Antioch, TN 37013 Phone: 615-832-1585 | |
Jamie Alison Fox, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3035 Hamilton Church Rd, Antioch, TN 37013 Phone: 615-360-3118 | |
Dr. Brian Francis Mcbride, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1345 Bell Rd Unit 416, Antioch, TN 37013 Phone: 856-655-0418 | |
Sandeep Virjee Dhokia, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2788 Murfreesboro Pike, Antioch, TN 37013 Phone: 615-367-2211 |